Exploring the Mechanism of Anemarrhena asphodeloides in the Treatment of Osteoporosis Based on Network Pharmacology, Molecular Docking, and Mendelian Randomization
Open Access
- 1 January 2025
- journal article
- Published by Wiley in BioMed Research International
- Vol. 2025 (1)
Abstract
Context: Osteoporosis is a systemic bone disease characterized by reduced bone density and quality. Anemarrhena asphodeloides shows therapeutic potential, but its mechanisms remain unclear. Objective: The aim of this study is to elucidate the potential mechanisms of Anemarrhena asphodeloides in the treatment of osteoporosis based on a combination of bioinformatics and experimental approaches. Materials and Methods: Anemarrhena asphodeloides ’ targets were sourced from TCMSP, while osteoporosis‐related genes came from GeneCards and OMIM. Overlapping targets (253) were analyzed via GO/KEGG. A PPI network (STRING/Cytoscape) identified core targets (degree > 5). Mendelian randomization integrated GWAS data, and molecular docking validated results. Results: Two hundred fifty‐three “drug–disease” intersection targets were obtained through screening. Five positive genes were obtained by Mendelian randomization, and the molecular docking results of key targets and core active ingredients were satisfactory. Discussion and Conclusion: Anemarrhena asphodeloides contains multiple active ingredients, which may exert therapeutic effects on osteoporosis by regulating targets such as AKR1C1, AKR1C2, ABCC1, SMO, and AKT1 and key signaling pathways like PI3K‐Akt and VEGF, thereby providing theoretical support for the clinical use of Anemarrhena asphodeloides in the treatment of osteoporosis.Keywords
This publication has 27 references indexed in Scilit:
- Advances in the study of polysaccharides from Anemarrhena asphodeloides Bge.: A reviewInternational Journal of Biological Macromolecules, 2024
- Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancerMolecular Biology Reports, 2024
- Association of Atrazine-Induced Overexpression of Aldo–Keto-Reductase 1C2 (AKR1C2) with Hypoandrogenism and Infertility: An Experimental Study in Male Wistar RatReproductive Sciences, 2024
- An insight into PI3k/Akt pathway and associated protein–protein interactions in metabolic syndrome: A recent updateJournal of Cellular Biochemistry, 2023
- Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formulaJournal of Ethnopharmacology, 2023
- OsteoporosisMedical Clinics of North America, 2023
- Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathwayFree Radical Biology and Medicine, 2021
- Hedgehog Signaling Controls Bone Homeostasis by Regulating Osteogenic/Adipogenic Fate of Skeletal Stem/Progenitor Cells in MiceJournal of Bone and Mineral Research, 2020
- The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacologyJournal of Ethnopharmacology, 2014
- Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formulaJournal of Ethnopharmacology, 2008